Cargando…
Adalimumab in patients with vision-threatening uveitis: real-world clinical experience
OBJECTIVES: Biologics are rapidly emerging as an effective vision saving addition to systemic uveitis therapy. The aim of this multicentre retrospective study is to review the outcomes of a large group of patients treated with adalimumab. METHODS: A retrospective chart review of patients with refrac...
Autores principales: | Tang Lee Say, Timothy Lee, Yang, Verlyn, Fingret, Jacob M, Zagora, Sophia, Symes, Richard, Younan, Christine, Cornish, Elisa Eleanor, Verma, Nitin, Sammel, Anthony, Wakefield, Denis, Speden, Deborah, McCluskey, Peter J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477319/ https://www.ncbi.nlm.nih.gov/pubmed/34632076 http://dx.doi.org/10.1136/bmjophth-2021-000819 |
Ejemplares similares
-
Systematic review of studies comparing infliximab and adalimumab in autoimmune uveitis
por: Mase, Oliver, et al.
Publicado: (2023) -
Comprehensive LncRNA and Potential Molecular Mechanism Analysis in Noninfectious Uveitis
por: Lu, Shiheng, et al.
Publicado: (2023) -
Risk factors for ocular toxoplasmosis among uveitis patients in Kinshasa, DR Congo
por: Nsiangani Lusambo, Nadine, et al.
Publicado: (2023) -
Bibliometric analysis of the uveitis literature and research trends over the past two decades
por: Gao, Tingxiao, et al.
Publicado: (2023) -
Occurrence of uveitis in a population-based cohort of inflammatory bowel diseases followed for 10 years: an observational study
por: Granstam, Elisabet, et al.
Publicado: (2023)